The latest announcement is out from IG Design ( (GB:IGR) ).

Norcros plc announced an Investor Presentation Webinar to discuss its Interim Results for the 27 weeks ending 5th October 2025. The event, led by CEO Thomas Willcocks and CFO James Eyre, is open to ...

Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop ...

TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...

Q3 2025 Earnings Call November 12, 2025 7:30 AM ESTCompany ParticipantsSean Washchuk - Senior VP & CFOGeoffrey Martin ...

Over 100 patients treated with AlloNK across autoimmune and oncology indications Refractory rheumatoid arthritis (RA) prioritized as lead indication following FDA Fast Track Designation for AlloNK®, ...

Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...

The Committee of the Whole recommended the Common Council approve the marina contract with Edgewater Resources.

During the third quarter of 2025 we continued strong execution of our financial strategy, resulting in improved equity, lower leverage and extended cash runway. Our cash runway has now been extended ...

Third quarter revenues rose by 11% year-over-year to $2.3 billion, fueled by $590 million of Services revenues, up 12% compared to the same period last year, and 34 aircraft deliveries, ...

After years of discussion and planning for the Chatham Park development, its South Village is beginning to take shape in its ...